查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1527307

全球支氣管內瓣膜市場規模研究，依產品類型（鴨嘴形、繖形）、最終用戶（醫院、臨床研究中心、門診手術中心等）及2022-2032年區域預測

Global Endobronchial Valves Market Size Study, by Product Type (Duckbill-Shaped, Umbrella-Shaped), by End User (Hospitals, Clinical Research Center, Ambulatory Surgery Center, Others) and Regional Forecasts 2022-2032
出版日期: | 出版商: Bizwit Research & Consulting LLP | 英文 285 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

2023年，全球支氣管內瓣膜市場價值約為1.7115億美元，預計在2024-2032年預測期內將以超過5.9%的健康成長率成長。支氣管內瓣膜是一種主要用於治療嚴重肺氣腫（慢性阻塞性肺病 (COPD) 的形式）的醫療設備。使用微創支氣管鏡檢查程序將這些小型單向閥植入肺部氣道。一旦就位，它們就會允許空氣排出肺部過度膨脹的患病部分，但會阻止空氣進入這些區域。此過程可減少肺部過度充氣，並將氣流重新引導至肺部更健康的部位，進而提高呼吸效率。透過緩解壓力和減少患病肺段的體積，支氣管內瓣膜有助於增強整體肺功能，緩解呼吸短促等症狀，並提高患者的生活品質。此手術通常適用於不適合進行肺部減容手術或肺移植等更具侵入性手術介入的患者。與肺部相關的健康問題，特別是慢性阻塞性肺病（COPD）的日益流行，正在推動對支氣管內瓣膜等創新醫療設備的需求。根據《美國呼吸與重症醫學雜誌》通報，慢性阻塞性肺病是死亡的主要原因，每年奪走約 300 萬人的生命。這令人震驚的統計數據強調了對有效治療方案的需求，包括支氣管內瓣膜促進的微創手術，由於減少了創傷，與傳統的開放性手術相比，這種手術越來越受到青睞。

根據世界衛生組織國際臨床試驗註冊平台報告，支氣管內瓣膜市場也受到大量針對 COPD 的臨床試驗的支持，其中有 600 多項正在進行的研究。這種活躍的研究格局凸顯了人們對發現慢性阻塞性肺病新治療方法日益成長的興趣和投資，預計這將推動支氣管內瓣膜市場向前發展。例如，2022 年 11 月在 MDPI 上發表的一項研究強調了慢性阻塞性肺病支氣管鏡治療的進展，反映了該領域為增強治療選擇所做的持續努力。此外，人們越來越認知到支氣管鏡肺減容術是治療肺部相關健康問題的可行方法，這進一步推動了市場的發展。然而，由於市場參與者數量有限，支氣管鏡瓣膜相關的成本較高，這對更廣泛的市場擴張構成了挑戰。

全球支氣管內瓣膜市場研究涵蓋的關鍵區域包括亞太地區、北美、歐洲、拉丁美洲、中東和非洲，由於慢性阻塞性肺病的高盛行率和健全的醫療保健，北美在 2023 年佔據最大的市場佔有率基礎設施。該地區對臨床試驗和創新治療的關注，以及 FDA 對 Zephyr 和 Spiration 閥門等設備的批准，鞏固了其市場主導地位。由於空氣污染和職業危害等因素導致人口老化和肺部疾病發病率上升，亞太地區預計將快速成長。

目錄

第 1 章：全球支氣管內瓣膜市場執行摘要

  • 全球支氣管內瓣膜市場規模及預測（2022-2032）
  • 區域概要
  • 分部摘要
    • 依產品類型
    • 按最終用戶
  • 主要趨勢
  • 經濟衰退的影響
  • 分析師推薦與結論

第 2 章：全球支氣管內瓣膜市場定義與研究假設

  • 研究目的
  • 市場定義
  • 研究假設
    • 包容與排除
    • 限制
    • 供給側分析
      • 可用性
      • 基礎設施
      • 監管環境
      • 市場競爭
      • 經濟可行性（消費者的角度）
    • 需求面分析
      • 監理框架
      • 技術進步
      • 環境考慮
      • 消費者意識和接受度
  • 估算方法
  • 研究涵蓋的年份
  • 貨幣兌換率

第 3 章：全球支氣管內瓣膜市場動態

  • 市場促進因素
    • 肺部相關問題的盛行率上升
    • 菸草消費量和吸菸率增加
  • 市場挑戰
    • 支氣管鏡瓣膜成本高
  • 市場機會
    • 醫療器材的技術進步
    • 越來越多的慢性阻塞性肺病治療臨床試驗

第 4 章：全球支氣管內瓣膜市場產業分析

  • 波特的五力模型
    • 供應商的議價能力
    • 買家的議價能力
    • 新進入者的威脅
    • 替代品的威脅
    • 競爭競爭
    • 波特五力模型的未來方法
    • 波特的 5 力影響分析
  • PESTEL分析
    • 政治的
    • 經濟
    • 社會的
    • 技術性
    • 環境的
    • 合法的
  • 頂級投資機會
  • 最佳制勝策略
  • 顛覆性趨勢
  • 產業專家視角
  • 分析師推薦與結論

第 5 章：全球支氣管內瓣膜市場規模與預測：依產品類型 - 2022-2032

  • 細分儀表板
  • 全球支氣管內瓣膜市場：2022 年及 2032 年產品類型收入趨勢分析
    • 鴨嘴形
    • 繖形

第 6 章：全球支氣管內瓣膜市場規模和預測：按最終用戶分類 - 2022-2032

  • 細分儀表板
  • 全球支氣管內瓣膜市場：2022 年和 2032 年最終用戶收入趨勢分析
    • 醫院
    • 臨床研究中心
    • 日間手術中心
    • 其他

第 7 章：全球支氣管內瓣膜市場規模及預測：按地區 - 2022-2032

  • 北美洲
    • 美國
    • 加拿大
  • 歐洲
    • 英國
    • 德國
    • 法國
    • 義大利
    • 荷蘭
    • 西班牙
    • 俄羅斯
    • 歐洲其他地區
  • 亞太
    • 中國
    • 印度
    • 日本
    • 馬來西亞
    • 印尼
    • 韓國
    • 亞太地區其他地區
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 阿根廷
    • 拉丁美洲其他地區
  • 中東和非洲
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 以色列
    • 南非
    • 中東和非洲其他地區

第 8 章：競爭情報

  • 重點企業SWOT分析
  • 頂級市場策略
  • 公司簡介
    • Pulmonx Corporation
      • 關鍵訊息
      • 概述
      • 財務（視數據可用性而定）
      • 產品概要
      • 市場策略
    • Olympus Corporation
    • Spiration Inc. (a subsidiary of Olympus)
    • Boston Scientific Corporation
    • Medtronic plc
    • Merit Medical Systems, Inc.
    • Broncus Medical Inc.
    • ALung Technologies, Inc.
    • BTG International Ltd. (a subsidiary of Boston Scientific)
    • PneumRx, Inc. (a BTG company)
    • Innovative Airway Solutions
    • IntraPace, Inc.
    • Uptake Medical Corporation
    • Novatech SA
    • TARIS Biomedical LLC

第 9 章：研究過程

  • 研究過程
    • 資料探勘
    • 分析
    • 市場預測
    • 驗證
    • 出版
  • 研究屬性
簡介目錄

Global Endobronchial Valves Market is valued approximately at USD 171.15 million in 2023 and is anticipated to grow with a healthy growth rate of more than 5.9% over the forecast period 2024-2032. Endobronchial valves are medical devices used primarily to treat severe emphysema, a form of chronic obstructive pulmonary disease (COPD). These small, one-way valves are implanted in the airways of the lungs using a minimally invasive bronchoscopy procedure. Once in place, they allow air to exit the over-inflated, diseased parts of the lungs but prevent air from entering these areas. This process reduces lung hyperinflation and redirects airflow to healthier parts of the lung, thereby improving breathing efficiency. By relieving pressure and reducing the volume of the diseased lung sections, endobronchial valves help enhance overall lung function, alleviate symptoms like shortness of breath, and improve the patient's quality of life. The procedure is generally considered for patients who are not candidates for more invasive surgical interventions like lung volume reduction surgery or lung transplantation. The increasing prevalence of lung-related health issues, notably chronic obstructive pulmonary disease (COPD), is driving the demand for innovative medical devices like endobronchial valves. COPD is a leading cause of mortality, claiming approximately 3 million lives annually, according to the American Journal of Respiratory and Critical Care Medicine. This alarming statistic underscores the need for effective treatment options, including minimally invasive procedures facilitated by endobronchial valves, which are increasingly preferred over traditional open surgeries due to reduced trauma.

The Endobronchial Valves Market is also bolstered by the significant number of clinical trials focused on COPD, as reported by the WHO International Clinical Trials Registry Platform, with over 600 ongoing studies. This active research landscape highlights the growing interest and investment in discovering new treatment methodologies for COPD, which is expected to propel the endobronchial valves market forward. For instance, a study published in MDPI in November 2022 emphasized the advancements in bronchoscopic management for COPD, reflecting the ongoing efforts to enhance therapeutic options in this field. Moreover, rising awareness about bronchoscopic lung volume reduction as a viable treatment for lung-related health issues is further driving the market. However, the high cost associated with bronchoscopic valves, driven by the limited number of market players, poses a challenge to broader market expansion.

The key regions considered for the Global Endobronchial Valves Market study include Asia Pacific, North America, Europe, Latin America, and the Middle East and Africa, North America held the largest market share in 2023, driven by the high prevalence of COPD and robust healthcare infrastructure. The region's focus on clinical trials and innovative treatments, alongside FDA approvals for devices like Zephyr and Spiration valves, reinforces its market dominance. The Asia Pacific region is expected to grow rapidly due to the aging population and increasing incidence of lung diseases, driven by factors such as air pollution and occupational hazards.

Major market players included in this report are:

  • Pulmonx Corporation
  • Olympus Corporation
  • Spiration Inc. (a subsidiary of Olympus)
  • Boston Scientific Corporation
  • Medtronic plc
  • Merit Medical Systems, Inc.
  • Broncus Medical Inc.
  • ALung Technologies, Inc.
  • BTG International Ltd. (a subsidiary of Boston Scientific)
  • PneumRx, Inc. (a BTG company)
  • Innovative Airway Solutions
  • IntraPace, Inc.
  • Uptake Medical Corporation
  • Novatech SA
  • TARIS Biomedical LLC

The detailed segments and sub-segment of the market are explained below:

By Product Type:

  • Duckbill-Shaped
  • Umbrella-Shaped

By End User:

  • Hospitals
  • Clinical Research Center
  • Ambulatory Surgery Center
  • Others

By Region:

  • North America
  • U.S.
  • Canada
  • Europe
  • UK
  • Germany
  • France
  • Italy
  • Spain
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • RoAPAC
  • Latin America
  • Brazil
  • Mexico
  • Rest of Latin America
  • Middle East & Africa
  • Saudi Arabia
  • South Africa
  • RoMEA

Years considered for the study are as follows:

  • Historical year - 2022
  • Base year - 2023
  • Forecast period - 2024 to 2032

Key Takeaways:

  • Market Estimates & Forecast for 10 years from 2022 to 2032.
  • Annualized revenues and regional level analysis for each market segment.
  • Detailed analysis of geographical landscape with Country level analysis of major regions.
  • Competitive landscape with information on major players in the market.
  • Analysis of key business strategies and recommendations on future market approach.
  • Analysis of competitive structure of the market.
  • Demand side and supply side analysis of the market.

Table of Contents

Chapter 1. Global Endobronchial Valves Market Executive Summary

  • 1.1. Global Endobronchial Valves Market Size & Forecast (2022-2032)
  • 1.2. Regional Summary
  • 1.3. Segmental Summary
    • 1.3.1. By Product Type
    • 1.3.2. By End User
  • 1.4. Key Trends
  • 1.5. Recession Impact
  • 1.6. Analyst Recommendation & Conclusion

Chapter 2. Global Endobronchial Valves Market Definition and Research Assumptions

  • 2.1. Research Objective
  • 2.2. Market Definition
  • 2.3. Research Assumptions
    • 2.3.1. Inclusion & Exclusion
    • 2.3.2. Limitations
    • 2.3.3. Supply Side Analysis
      • 2.3.3.1. Availability
      • 2.3.3.2. Infrastructure
      • 2.3.3.3. Regulatory Environment
      • 2.3.3.4. Market Competition
      • 2.3.3.5. Economic Viability (Consumer's Perspective)
    • 2.3.4. Demand Side Analysis
      • 2.3.4.1. Regulatory Frameworks
      • 2.3.4.2. Technological Advancements
      • 2.3.4.3. Environmental Considerations
      • 2.3.4.4. Consumer Awareness & Acceptance
  • 2.4. Estimation Methodology
  • 2.5. Years Considered for the Study
  • 2.6. Currency Conversion Rates

Chapter 3. Global Endobronchial Valves Market Dynamics

  • 3.1. Market Drivers
    • 3.1.1. Rising Prevalence of Lung-Related Issues
    • 3.1.2. Increasing Tobacco Consumption and smoking rate
  • 3.2. Market Challenges
    • 3.2.1. High Cost of Bronchoscopic Valves
  • 3.3. Market Opportunities
    • 3.3.1. Technological Advancements in Medical Devices
    • 3.3.2. Growing Clinical Trials for COPD Treatments

Chapter 4. Global Endobronchial Valves Market Industry Analysis

  • 4.1. Porter's 5 Force Model
    • 4.1.1. Bargaining Power of Suppliers
    • 4.1.2. Bargaining Power of Buyers
    • 4.1.3. Threat of New Entrants
    • 4.1.4. Threat of Substitutes
    • 4.1.5. Competitive Rivalry
    • 4.1.6. Futuristic Approach to Porter's 5 Force Model
    • 4.1.7. Porter's 5 Force Impact Analysis
  • 4.2. PESTEL Analysis
    • 4.2.1. Political
    • 4.2.2. Economical
    • 4.2.3. Social
    • 4.2.4. Technological
    • 4.2.5. Environmental
    • 4.2.6. Legal
  • 4.3. Top Investment Opportunity
  • 4.4. Top Winning Strategies
  • 4.5. Disruptive Trends
  • 4.6. Industry Expert Perspective
  • 4.7. Analyst Recommendation & Conclusion

Chapter 5. Global Endobronchial Valves Market Size & Forecasts by Product Type 2022-2032

  • 5.1. Segment Dashboard
  • 5.2. Global Endobronchial Valves Market: Product Type Revenue Trend Analysis, 2022 & 2032 (USD Million)
    • 5.2.1. Duckbill-Shaped
    • 5.2.2. Umbrella-Shaped

Chapter 6. Global Endobronchial Valves Market Size & Forecasts by End User 2022-2032

  • 6.1. Segment Dashboard
  • 6.2. Global Endobronchial Valves Market: End User Revenue Trend Analysis, 2022 & 2032 (USD Million)
    • 6.2.1. Hospitals
    • 6.2.2. Clinical Research Center
    • 6.2.3. Ambulatory Surgery Center
    • 6.2.4. Others

Chapter 7. Global Endobronchial Valves Market Size & Forecasts by Region 2022-2032

  • 7.1. North America Endobronchial Valves Market
    • 7.1.1. U.S. Endobronchial Valves Market
      • 7.1.1.1. Product Type breakdown size & forecasts, 2022-2032
      • 7.1.1.2. End User breakdown size & forecasts, 2022-2032
    • 7.1.2. Canada Endobronchial Valves Market
  • 7.2. Europe Endobronchial Valves Market
    • 7.2.1. UK Endobronchial Valves Market
    • 7.2.2. Germany Endobronchial Valves Market
    • 7.2.3. France Endobronchial Valves Market
    • 7.2.4. Italy Endobronchial Valves Market
    • 7.2.5. Netherlands Endobronchial Valves Market
    • 7.2.6. Spain Endobronchial Valves Market
    • 7.2.7. Russia Endobronchial Valves Market
    • 7.2.8. Rest of Europe Endobronchial Valves Market
  • 7.3. Asia-Pacific Endobronchial Valves Market
    • 7.3.1. China Endobronchial Valves Market
    • 7.3.2. India Endobronchial Valves Market
    • 7.3.3. Japan Endobronchial Valves Market
    • 7.3.4. Malaysia Endobronchial Valves Market
    • 7.3.5. Indonesia Endobronchial Valves Market
    • 7.3.6. South Korea Endobronchial Valves Market
    • 7.3.7. Rest of Asia Pacific Endobronchial Valves Market
  • 7.4. Latin America Endobronchial Valves Market
    • 7.4.1. Brazil Endobronchial Valves Market
    • 7.4.2. Mexico Endobronchial Valves Market
    • 7.4.3. Argentina Endobronchial Valves Market
    • 7.4.4. Rest of Latin America Endobronchial Valves Market
  • 7.5. Middle East & Africa Endobronchial Valves Market
    • 7.5.1. Saudi Arabia Endobronchial Valves Market
    • 7.5.2. UAE Endobronchial Valves Market
    • 7.5.3. Israel Endobronchial Valves Market
    • 7.5.4. South Africa Endobronchial Valves Market
    • 7.5.5. Rest of Middle East & Africa Endobronchial Valves Market

Chapter 8. Competitive Intelligence

  • 8.1. Key Company SWOT Analysis
  • 8.2. Top Market Strategies
  • 8.3. Company Profiles
    • 8.3.1. Pulmonx Corporation
      • 8.3.1.1. Key Information
      • 8.3.1.2. Overview
      • 8.3.1.3. Financial (Subject to Data Availability)
      • 8.3.1.4. Product Summary
      • 8.3.1.5. Market Strategies
    • 8.3.2. Olympus Corporation
    • 8.3.3. Spiration Inc. (a subsidiary of Olympus)
    • 8.3.4. Boston Scientific Corporation
    • 8.3.5. Medtronic plc
    • 8.3.6. Merit Medical Systems, Inc.
    • 8.3.7. Broncus Medical Inc.
    • 8.3.8. ALung Technologies, Inc.
    • 8.3.9. BTG International Ltd. (a subsidiary of Boston Scientific)
    • 8.3.10. PneumRx, Inc. (a BTG company)
    • 8.3.11. Innovative Airway Solutions
    • 8.3.12. IntraPace, Inc.
    • 8.3.13. Uptake Medical Corporation
    • 8.3.14. Novatech SA
    • 8.3.15. TARIS Biomedical LLC

Chapter 9. Research Process

  • 9.1. Research Process
    • 9.1.1. Data Mining
    • 9.1.2. Analysis
    • 9.1.3. Market Estimation
    • 9.1.4. Validation
    • 9.1.5. Publishing
  • 9.2. Research Attributes